Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$930B
| $1.23B | 0.59% |
4,175,138
-18,473
| -0.4% | -$5.61M |
|
27
Danaher
DHR
$135B
| $1.22B | 0.58% |
6,489,965
-327,641
| -5% | -$69.8M |
|
28
Amphenol
APH
$194B
| $1.2B | 0.57% |
9,458,488
-446,139
| -5% | -$62.8M |
|
|
29
DoorDash
DASH
$74B
| $1.16B | 0.55% |
7,762,553
+2,225,954
| +40% | +$411M |
|
30
Booking.com
BKNG
$134B
| $1.14B | 0.54% |
6,750,475
-1,214,750
| -15% | -$224M |
|
31
Praxis Precision Medicines
PRAX
$8.99B
| $1.11B | 0.53% |
3,458,863
+218,777
| +7% | +$67.7M |
|
32
LPL Financial
LPLA
$25.9B
| $1.1B | 0.53% |
3,666,780
+289,227
| +9% | +$97M |
|
33
Mercado Libre
MELI
$91.2B
| $1.06B | 0.51% |
614,238
+10,142
| +2% | +$19.6M |
|
34
TotalEnergies
TTE
$191B
| $1.06B | 0.5% |
11,349,122
+2,287,500
| +25% | +$175M |
|
35
Madrigal Pharmaceuticals
MDGL
$12.5B
| $1.05B | 0.5% |
2,018,647
+433,804
| +27% | +$207M |
|
36
Boston Scientific
BSX
$64.8B
| $1.04B | 0.49% |
16,497,366
+3,907,981
| +31% | +$313M |
|
37
UnitedHealth
UNH
$385B
| $991M | 0.47% |
3,691,607
+89,359
| +2% | +$26.6M |
|
38
Intercontinental Exchange
ICE
$81B
| $988M | 0.47% |
6,315,981
-233,615
| -4% | -$38.1M |
|
39
BridgeBio Pharma
BBIO
$16.2B
| $979M | 0.47% |
13,179,013
+2,178,556
| +20% | +$158M |
|
40
Vaxcyte
PCVX
$8.03B
| $960M | 0.46% |
16,575,875
+3,188,687
| +24% | +$173M |
|
41
Vertex Pharmaceuticals
VRTX
$120B
| $952M | 0.45% |
2,131,527
-90,426
| -4% | -$42.2M |
|
42
Revolution Medicines
RVMD
$40.1B
| $950M | 0.45% |
9,766,496
-2,537,006
| -21% | -$256M |
|
43
APi Group
APG
$17.1B
| $947M | 0.45% |
23,367,041
+250,873
| +1% | +$10.6M |
|
44
Progressive
PGR
$120B
| $938M | 0.45% |
4,731,581
-715,686
| -13% | -$148M |
|
45
Teledyne Technologies
TDY
$30.2B
| $935M | 0.45% |
1,545,674
-147,607
| -9% | -$92.1M |
|
46
GE Aerospace
GE
$362B
| $926M | 0.44% |
3,263,621
-294,734
| -8% | -$92.6M |
|
47
Liberty Media Series C
FWONK
$24.2B
| $925M | 0.44% |
10,883,212
+302,191
| +3% | +$26.4M |
|
48
Datadog
DDOG
$87B
| $906M | 0.43% |
7,749,569
+1,439,082
| +23% | +$178M |
|
49
Alphabet (Google) Class A
GOOGL
$3.88T
| $885M | 0.42% |
3,078,924
+531,699
| +21% | +$167M |
|
50
Chevron
CVX
$387B
| $865M | 0.41% |
4,181,809
-695,236
| -14% | -$127M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.